Bonk, INC. (BNKK) — SEC Filings

Overview

Bonk, INC. (BNKK) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-3 filed on Apr 17, 2026: BONK, INC. filed an S-3 registration statement on April 17, 2026, indicating plans to potentially offer securities. The filing does not specify the amount or type of securities to be offered, nor does it name underwriters. The company is in the Perfumes, Cosmetics & Other Toilet Preparations industr

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 5 bearish, 42 neutral, 3 mixed. The dominant filing sentiment for Bonk, INC. is neutral.

Filing Type Overview

Bonk, INC. (BNKK) has filed 1 S-3, 33 8-K, 2 S-1, 2 DEF 14A, 3 10-Q, 1 8-K/A, 4 S-1/A, 3 DEFA14A, 1 10-K with the SEC between Feb 2025 to Apr 2026.

Filings by Year

2026 · 2025

Recent Filings (50)

• BONK, INC. Files S-3 Registration Statement — S-3 · Apr 17, 2026 Risk: medium
  BONK, INC. filed an S-3 registration statement on April 17, 2026, indicating plans to potentially offer securities. The filing does not specify the amount or ty
• BONK, INC. Files 8-K on Security Holder Vote — 8-K · Dec 29, 2025 Risk: medium
  BONK, INC. filed an 8-K on December 29, 2025, reporting on a matter submitted to a vote of security holders as of December 22, 2025. The company, formerly known
• 8-K Filing — 8-K · Dec 12, 2025
• BONK, INC. Pivots to DeFi, Registers 31.8M Shares for Resale — S-1 · Dec 10, 2025 Risk: high
  BONK, INC. (BNKK) is filing an S-1 to register 31,839,533 shares of common stock for resale by selling stockholders, including 30,000,054 shares from the July 2
• BONK, INC. Files 8-K: Corporate Updates — 8-K · Dec 8, 2025 Risk: low
  On December 3, 2025, BONK, INC. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as S
• BONK Sets Virtual Shareholder Meeting, Board Seeks Re-election & Auditor Ratification — DEF 14A · Dec 1, 2025 Risk: medium
  BONK, INC. (BNKK) is holding its 2025 Annual Meeting of Stockholders virtually on December 22, 2025, at 10:00 AM Eastern Time. Stockholders will vote on two key
• BONK's Q3 Loss Widens to $33.6M Amid Digital Asset Hit, Yerba Integration — 10-Q · Nov 19, 2025 Risk: high
  BONK, INC. (BNKK) reported a net loss of $33,581,216 for the three months ended September 30, 2025, a significant increase from the $11,929,277 net loss in the
• BONK, INC. Changes Fiscal Year End — 8-K · Nov 7, 2025 Risk: low
  BONK, INC. filed an 8-K on November 7, 2025, reporting a change in its fiscal year end to December 31. The company, formerly known as Safety Shot, Inc., Jupiter
• BONK, INC. Faces Delisting Concerns, Executive Changes — 8-K · Nov 6, 2025 Risk: high
  BONK, INC. filed an 8-K on November 6, 2025, reporting a notice of delisting or failure to satisfy continued listing rules, a director's departure, and the appo
• BONK, INC. Files 8-K on Shareholder Votes — 8-K · Nov 4, 2025 Risk: low
  BONK, INC. filed an 8-K on November 4, 2025, reporting on matters submitted to a vote of security holders as of October 31, 2025. The company, formerly known as
• BONK, INC. Files 8-K/A Amendment — 8-K/A · Oct 16, 2025 Risk: low
  BONK, INC. filed an amendment (8-K/A) on October 16, 2025, related to a material definitive agreement entered into on August 25, 2025. The company was formerly
• BONK, INC. Files 8-K: Director Changes, Compensation, Bylaw Amendments — 8-K · Oct 14, 2025 Risk: medium
  BONK, INC. filed an 8-K on October 14, 2025, reporting several key events. These include the departure of a director, the election of a new director, and change
• Safety Shot, Inc. Files 8-K: Agreements, Officer Changes, Financials — 8-K · Oct 8, 2025 Risk: medium
  Safety Shot, Inc. announced on October 3, 2025, a material definitive agreement related to its business. The filing also details the departure of directors or c
• Safety Shot Seeks Quadruple Stock Authorization for Financing, Nasdaq Compliance — DEF 14A · Oct 6, 2025 Risk: high
  Safety Shot, Inc. (BNKK) is seeking stockholder approval to significantly increase its authorized common stock from 250,000,000 shares to 1,000,000,000 shares.
• Safety Shot Appoints Dr. Patrick as CMO, Director — 8-K · Sep 9, 2025 Risk: medium
  On September 5, 2025, Safety Shot, Inc. filed an 8-K report detailing several key events. The company announced the departure of director Dr. Philip Patrick, ef
• Safety Shot Appoints New Director, Announces Officer Compensation — 8-K · Sep 4, 2025 Risk: medium
  On August 29, 2025, Safety Shot, Inc. filed an 8-K report detailing the departure of director Dr. David G. Wild, effective August 23, 2025. The company also ann
• Safety Shot, Inc. Files 8-K for Equity Sale — 8-K · Aug 29, 2025 Risk: medium
  On August 25, 2025, Safety Shot, Inc. entered into a material definitive agreement related to the unregistered sale of equity securities. The company, formerly
• Safety Shot, Inc. Files 8-K with Corporate Updates — 8-K · Aug 19, 2025 Risk: low
  On August 15, 2025, Safety Shot, Inc. filed an 8-K report detailing amendments to its articles of incorporation and bylaws. The company also reported on other e
• Safety Shot Swings to Profit on $18M Equity Gain, Sales Plummet — 10-Q · Aug 14, 2025 Risk: high
  Safety Shot, Inc. (BNKK) reported a significant turnaround, achieving a net income of $13.37 million for the three months ended June 30, 2025, compared to a net
• Safety Shot, Inc. Files 8-K on Director Changes & Compensation — 8-K · Aug 5, 2025 Risk: medium
  Safety Shot, Inc. filed an 8-K on August 5, 2025, reporting on the departure of a director, the election of new directors, and compensatory arrangements. The fi
• Safety Shot Appoints New Director, Modifies Officer Compensation — 8-K · Jul 31, 2025 Risk: medium
  On July 25, 2025, Safety Shot, Inc. filed an 8-K report detailing the departure of director Dr. David G. Bruce and the appointment of Dr. Michael L. Glick as a
• Safety Shot, Inc. Files 8-K for Material Agreement — 8-K · Jul 24, 2025 Risk: medium
  On July 21, 2025, Safety Shot, Inc. entered into a material definitive agreement related to the sale of unregistered equity securities. The company also reporte
• Safety Shot, Inc. Enters Material Definitive Agreement — 8-K · Jul 17, 2025 Risk: medium
  On July 14, 2025, Safety Shot, Inc. entered into a material definitive agreement related to its common stock. The company, formerly known as Jupiter Wellness, I
• Safety Shot Faces Delisting Notice Amid Material Agreement — 8-K · Jul 15, 2025 Risk: high
  On July 9, 2025, Safety Shot, Inc. filed an 8-K report detailing a material definitive agreement and a notice of potential delisting. The company is facing a po
• Safety Shot, Inc. Files 8-K for Equity Sales and Amendments — 8-K · Jul 9, 2025 Risk: medium
  On July 2, 2025, Safety Shot, Inc. entered into a material definitive agreement related to unregistered sales of equity securities. The company also amended its
• Safety Shot, Inc. Files 8-K for Material Agreement — 8-K · Jul 2, 2025 Risk: medium
  On June 30, 2025, Safety Shot, Inc. entered into a Material Definitive Agreement related to its financial statements and exhibits. The company, formerly known a
• Safety Shot, Inc. Files 8-K on June 30, 2025 — 8-K · Jun 30, 2025 Risk: low
  On June 30, 2025, Safety Shot, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as Jupiter Wellness, Inc. a
• Safety Shot, Inc. Files 8-K with Acquisition, Debt, and Equity Updates — 8-K · Jun 27, 2025 Risk: medium
  On June 27, 2025, Safety Shot, Inc. filed an 8-K detailing several significant events. These include the completion of an acquisition or disposition of assets,
• Safety Shot, Inc. Files 8-K for Equity Deal — 8-K · Jun 23, 2025 Risk: medium
  On June 16, 2025, Safety Shot, Inc. entered into a material definitive agreement related to the sale of unregistered equity securities. The company, formerly kn
• Safety Shot, Inc. Files 8-K Report — 8-K · Jun 20, 2025 Risk: low
  On June 20, 2025, Safety Shot, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known
• Safety Shot Appoints New CMO, Adds Director, Raises $10M — 8-K · Jun 16, 2025 Risk: medium
  On June 12, 2025, Safety Shot, Inc. announced the appointment of Dr. David Wu as Chief Medical Officer and the election of Ms. Anya Sharma to its Board of Direc
• Safety Shot, Inc. Files 8-K with Financials — 8-K · Jun 13, 2025 Risk: medium
  On June 13, 2025, Safety Shot, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known
• Safety Shot, Inc. Files 8-K for Material Definitive Agreement — 8-K · Jun 4, 2025 Risk: medium
  On May 29, 2025, Safety Shot, Inc. entered into a material definitive agreement related to its common stock. The company, formerly known as Jupiter Wellness, In
• Safety Shot, Inc. Files 8-K with Financials — 8-K · Jun 3, 2025 Risk: medium
  On June 3, 2025, Safety Shot, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known a
• Safety Shot Amends S-1/A, Details Capital Structure & Partnerships — S-1/A · Jun 2, 2025 Risk: high
  Safety Shot, Inc. (BNKK) filed an S-1/A on June 2, 2025, indicating a registration statement amendment. The filing covers the period from January 1, 2025, to Ma
• Safety Shot Inc. Files Definitive Proxy Statement — DEFA14A · May 29, 2025 Risk: low
  Safety Shot, Inc. filed a DEFA14A on May 29, 2025, detailing its annual meeting of stockholders. The company, formerly known as Jupiter Wellness, Inc. and CBD B
• Safety Shot, Inc. Files DEFA14A — DEFA14A · May 28, 2025 Risk: low
  Safety Shot, Inc. filed a DEFA14A on May 28, 2025, detailing information related to its annual meeting or other shareholder matters. The company, formerly known
• Safety Shot, Inc. Files 8-K for Warrant Exercise — 8-K · May 27, 2025 Risk: medium
  On May 20, 2025, Safety Shot, Inc. entered into a material definitive agreement, specifically a warrant exercise agreement. This agreement involves the exercise
• Safety Shot, Inc. Files DEFA14A Proxy Statement — DEFA14A · May 23, 2025 Risk: low
  Safety Shot, Inc. filed a DEFA14A on May 23, 2025, detailing its proxy statement. The company, formerly known as Jupiter Wellness, Inc. and CBD Brands, Inc., is
• Safety Shot, Inc. Files S-1 — S-1 · May 19, 2025 Risk: medium
  Safety Shot, Inc. filed an S-1 form on May 19, 2025, detailing its business operations and financial status. The company, formerly known as Jupiter Wellness, In
• Safety Shot, Inc. Files Q1 2025 Quarterly Report — 10-Q · May 15, 2025 Risk: medium
  Safety Shot, Inc. filed its quarterly report on March 31, 2025, detailing its financial performance. The company, formerly known as Jupiter Wellness, Inc. and C
• Safety Shot, Inc. Files 8-K with Equity Sales and Bylaw Amendments — 8-K · May 7, 2025 Risk: medium
  On May 2, 2025, Safety Shot, Inc. entered into a material definitive agreement related to the sale of unregistered equity securities. The company also amended i
• Safety Shot, Inc. Files S-1/A Amendment — S-1/A · Apr 16, 2025 Risk: medium
  Safety Shot, Inc. filed an S-1/A amendment on April 16, 2025, to its registration statement. The company, formerly known as Jupiter Wellness, Inc. and CBD Brand
• Safety Shot, Inc. Files S-1/A Amendment — S-1/A · Apr 10, 2025 Risk: medium
  Safety Shot, Inc. filed an S-1/A amendment on April 10, 2025, detailing its business operations and financial status. The company, formerly known as Jupiter Wel
• Safety Shot, Inc. Files S-1/A Amendment — S-1/A · Apr 4, 2025 Risk: medium
  Safety Shot, Inc. filed an S-1/A on April 4, 2025, detailing its business operations and financial status. The company, formerly known as Jupiter Wellness, Inc.
• Safety Shot, Inc. Files 8-K with Financial Exhibits — 8-K · Mar 31, 2025 Risk: low
  On March 31, 2025, Safety Shot, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures rel
• Safety Shot, Inc. Files 2024 10-K — 10-K · Mar 28, 2025 Risk: medium
  Safety Shot, Inc. filed its 2024 10-K on March 28, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Jupiter Wellness,
• Safety Shot, Inc. Files 8-K for Material Agreement — 8-K · Mar 19, 2025 Risk: medium
  On March 13, 2025, Safety Shot, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company, for
• Safety Shot, Inc. Files 8-K Report — 8-K · Mar 4, 2025 Risk: low
  On March 4, 2025, Safety Shot, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The compa
• Safety Shot, Inc. Files 8-K with Financials — 8-K · Feb 28, 2025 Risk: low
  Safety Shot, Inc. filed an 8-K on February 28, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known

Risk Profile

Risk Assessment: Of BNKK's 49 recent filings, 7 were flagged as high-risk, 29 as medium-risk, and 13 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Bonk, INC.'s most recent 10-Q filing (Nov 19, 2025):

• Revenue: $1,514,817
• Net Income: -$33,581,216
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: N/A
• Operating Margin: N/A
• Total Assets: $81,041,676
• Total Debt: N/A

Key Executives

• Jarrett Boon
• Joseph M. Lucosky, Esq.
• James McAvity
• Stacey Duffy
• Connor Klein
• Mitchell Rudy
• David Sandler
• Dr. Philip Patrick
• Dr. David G. Wild
• Dr. Michael J. R. Smith
• Dr. David G. Bruce
• Dr. Michael L. Glick
• Dr. David Wu
• Ms. Anya Sharma

Industry Context

BONK, INC. is pivoting into the rapidly evolving digital asset and decentralized finance (DeFi) sectors. This space is characterized by high innovation, significant growth potential, and intense competition from established technology companies and numerous startups. The industry is also subject to rapid technological advancements and increasing regulatory scrutiny globally.

Top Tags

corporate-governance (8) · filing (8) · financials (8) · material-agreement (7) · amendment (6) · corporate-actions (6) · management-change (5) · corporate-filing (4) · equity-sale (4) · warrants (4)

Key Numbers

• S-3 Document Size: 319505 — Size of the primary S-3 filing document in bytes.
• Complete Submission Text File Size: 598975 — Size of the complete submission text file in bytes.
• SEC File Number: 001-39569 — Identifies the company's filing history with the SEC.
• EIN: 83-2455880 — Employer Identification Number for tax purposes.
• Shares of Common Stock: 31,839,533 — Total shares registered for resale by Selling Stockholders.
• Par Value: $0.001 — Par value per share of common stock.
• Last Reported Sale Price: $0.1974 — Per share on NASDAQ Capital Market as of December 5, 2025.
• Authorized Shares of Common Stock: 1,000,000,000 — Increased from 250,000,000 on November 4, 2025.
• Gross Cash Proceeds: $4,250,000 — From August 2025 Registered Direct Offering.
• Shares Issued: 9,239,044 — In August 2025 Registered Direct Offering.
• Offering Price: $0.46 — Per share in August 2025 Registered Direct Offering.
• Common Stock Votes: 185,476,283 — Total votes for common stock as of November 20, 2025 Record Date
• Series A Preferred Stock Votes: 6,816,832 — Total votes for Series A Convertible Preferred Stock as of November 20, 2025 Record Date
• Series B Preferred Stock Votes: 3,999,265 — Total votes for Series B Convertible Preferred Stock as of November 20, 2025 Record Date
• Series C Preferred Stock Votes: 124,884,366 — Total votes for Series C Convertible Preferred Stock as of November 20, 2025 Record Date

Related Companies

BNKKW · SHOT · SHOTW

Frequently Asked Questions